Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
18,514,506
-
Shares change
-
-2,801,954
-
Total reported value, excl. options
-
$216,255,359
-
Value change
-
-$34,732,608
-
Put/Call ratio
-
778%
-
Number of buys
-
59
-
Number of sells
-
-52
-
Price
-
$11.68
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q2 2017
123 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q2 2017.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,514,506 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (5,032,313 shares), FMR LLC (2,790,142 shares), JPMORGAN CHASE & CO (2,466,752 shares), BlackRock Inc. (2,201,509 shares), VANGUARD GROUP INC (1,206,436 shares), Foresite Capital Management III, LLC (452,727 shares), STATE STREET CORP (416,966 shares), NORTHERN TRUST CORP (341,555 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (270,674 shares), and SPHERA FUNDS MANAGEMENT LTD. (250,000 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.